Teva will exclusively commercialize two new biosimilar candidates and two line extensions of current biosimilars in the U.S., developed and manufactured by Alvotech.
Rite Aid shared its progress across its four key pillars, focused on areas such as environmental sustainability, responsible sourcing, employee benefits and more.